Superbolan 400 - Test-Mast-Tren Formula 400 - PHARMAQO

Superbolan 400 for sale in the UK

Superbolan 400 is a Pharmaqo Labs injectable blend that combines Trenbolone Enanthate, Drostanolone Enanthate and Testosterone Enanthate at a total concentration of 400 mg/ml. It is intended for advanced bodybuilders running cutting or recomposition cycles — buy Superbolan 400 UK from Power Anabolics with same-day dispatch and discreet tracked delivery.

What is the Test-Mast-Tren blend?

Superbolan 400 stacks three long-ester injectables into a single oil. Testosterone Enanthate 200 mg/ml acts as the anabolic and androgenic base, supporting recovery and offsetting the libido suppression caused by 19-nor compounds. Trenbolone Enanthate 100 mg/ml is a powerful 19-nortestosterone derivative that drives lean tissue gain, nutrient partitioning and fat oxidation without aromatising to oestrogen. Drostanolone Enanthate 100 mg/ml is a DHT derivative that adds muscle hardness, mild anti-oestrogenic activity and a drier visual finish. All three esters share an active half-life of roughly 7–11 days, so a single weekly injection delivers stable serum levels — although twice-weekly dosing produces smoother peaks and is preferred by most experienced users.

Superbolan 400 benefits

• Three popular cutting/recomp compounds in one injection — fewer pins, simpler logistics
• Pronounced strength gains driven by the Trenbolone component
• Hardening and dry, defined look from the Drostanolone component
• Improved nutrient partitioning — lean gains with reduced fat retention
• Stable long-ester profile suited to 10–12 week protocols

The blend is positioned as a single-vial answer for users who would otherwise be running Test E, Tren E and Mast E from three separate vials.

Superbolan 400 dosage and cycle

Beginners: not recommended — Trenbolone is not a first-cycle compound. Intermediate: 400–600 mg/week (1–1.5 ml). Advanced: 600–800 mg/week (1.5–2 ml). Cycle length is typically 10–12 weeks, with injections split into two equal doses (e.g. Monday/Thursday) to keep blood levels even. Onset is 2–4 weeks; the Trenbolone effect plateaus by week three or four. Not suitable for women due to the strongly virilising Trenbolone component.

Side effects and PCT

Expect Tren-specific issues: night sweats, insomnia, increased aggression, cardiovascular strain and elevated prolactin. Running Cabaser (cabergoline) at 0.25–0.5 mg twice weekly controls prolactin and protects libido. Testosterone aromatisation should be managed with an aromatase inhibitor such as Arimidex if oestrogenic symptoms appear. Acne, oily skin and male-pattern hair loss are likely in genetically predisposed users. Hepatotoxicity is not a concern — none of the three esters is 17-alpha-alkylated, so liver markers are typically unaffected at sensible doses. Blood pressure should be monitored throughout. After the cycle, run PCT Tabs for 4 weeks to restart natural testosterone production.

Stacks well with

Users who prefer to dose components individually can run the same protocol with separate vials of Trenbolone E200, Masteron E200 and Proper Enan 300 for finer dose control. Superbolan 400 itself is rarely stacked further — it already contains a complete cutting matrix.

Frequently asked questions

How long does Superbolan 400 take to start working?

The Testosterone Enanthate component begins to lift performance within 10–14 days. The Trenbolone effect builds more gradually and plateaus around week three to four, so most users report noticeable strength and hardness changes by the end of the first month.

Is Superbolan 400 suitable for first-time users?

No. Superbolan 400 contains Trenbolone, which is one of the harshest commonly used anabolics. Beginners should run a single-compound testosterone cycle first to gauge response. The blend is intended for advanced users with several cycles of experience and established blood-work habits.

Can Superbolan 400 be detected on a drug test?

Yes. Trenbolone Enanthate metabolites are detectable in urine for approximately four to five months after the final injection — longer than the Test E or Mast E components. Tested athletes should treat the 4–5 month figure as the binding detection window.